healthtech-logo
Submit Press Release
  • News
  • Resources
    • Newsletter
  • Insights
    • Interviews
    • Featured Articles
    • Guest Posts
  • Contact
  • News
  • Resources
    • Newsletter
  • Insights
    • Interviews
    • Featured Articles
    • Guest Posts
  • Contact
Advertise with us
Submit Press Release

Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments

Read More »
October 2, 2025

ExQor Advances Brain Therapy for Alzheimer’s Clinical Trials

Read More »
October 2, 2025

GSK and IQVIA Launch Local Vaccine Data for Public Health

Read More »
October 1, 2025

SpotitEarly, Hackensack Team Up on Cancer Detection Dogs

Read More »
September 30, 2025

Lumata Health Boosts Patient Adherence to Vision Treatments

Read More »
September 30, 2025
Leo Cancer Care Launches Grace Upright Photon Therapy System

Leo Cancer Care Launches Grace Upright Photon Therapy System

Read More »
September 29, 2025

Kedrion Biopharma Gains FDA Approval for QIVIGY in PI Treatment

Read More »
September 29, 2025

Baxter Earns HIRC Gold Resiliency Badge for IV and Nutrition Solutions

Read More »
September 26, 2025

Lundbeck Collaborates with Migraine Community to Raise the Bar for Migraine Care

Read More »
September 25, 2025
Sandoz Launches Affordable Iron Sucrose Injection in US

Sandoz Launches Affordable Iron Sucrose Injection in US

Read More »
September 25, 2025

PocketRN and Comfort Keepers Partner for CMS GUIDE Dementia Care

Read More »
September 24, 2025

Actio Biosciences Begins Trial for KCNT1 Epilepsy Treatment

Read More »
September 23, 2025
Load More

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 26 November 2025

FluidAI Medical Announces an Acquisition Deal With Emmetros Limited

Healgen Highlights Rapid Check Test for COVID-19 and Flu Season

Alleva Earns ONC Certification, SOC 2, and HIPAA Compliance

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096

Fuel up with free Health Tech Insights

Quick Links

  • About
  • News
  • Newsletter
  • Write for Us

Insights

  • Interviews
  • Articles
  • Guest Post

Get in touch

  • Do Not Sell My Information
  • Privacy Policy
  • Contact Us

Follow Us

  • Linkedin Linkedin
Our Other Brands
Intenttech Martech Cybertech Fintech Hrtech Aitech contactcenter

Copyright © 2025  All Rights Reserved. Health Technology Insights. An Intent Amplify® Product.